Arinzon Zeev, Peisakh Alexander, Zuta Aneta, Berner Yitshal N
Department of Geriatric Medicine, Meir Hospital, Kfar Saba, Israel.
Drugs Aging. 2006;23(2):157-65. doi: 10.2165/00002512-200623020-00005.
Advanced age, co-morbid diseases, functional dependence and frailty are associated with polypharmacy and overall high health expenditures. Polypharmacy is commonly defined as the concomitant ingestion of four or more medications, particularly in community-dwelling patients, but the number of drugs being taken by institutionalised and hospitalised patients may be as high as ten. The aim of this study was to compare drug use in newly admitted patients (AP) to a geriatric medical centre for long-term care (LTC) with that of institutionalised patients (IP) at the centre.
A cross-sectional study was conducted, between January 2001 and December 2002, in 324 functionally dependent and cognitively impaired elderly patients (> or = 65 years of age), consisting of 167 IP (127 females, 40 males) staying at the centre for > or = 3 months and 157 (117 females, 40 males) consecutive new admissions for LTC. All patients underwent a comprehensive geriatric assessment, which included a structured medical history, history of drug use, physical examination and functional and cognitive examinations. Overall drug use, drug categories and the basis of use (regular and/or as needed) were compared between the two groups of patients. The pattern of drug use was defined as use of drugs either on a 'regular' basis or on an 'as needed' basis at any time during the 3 weeks preceding the comprehensive geriatric assessment.
IPs were younger, more dependent, more cognitively impaired, had more co-morbidity and had nonsignificantly higher overall drug use than APs. APs used drugs mainly on a 'regular' basis. All of the IPs and most (97%) of the APs were taking drugs according to regular regimens. However, advanced age in IPs was associated with lower overall drug use, predominantly of medications taken on a 'regular' basis, and higher use of drugs taken on an 'as needed' basis, whereas in APs, advanced age was associated with higher use of both types of medications.
IPs used more drugs on an 'as needed' basis, probably because of closer medical supervision of these patients than those in the community. Better knowledge of the patient's medical condition and treatment, together with better monitoring in the community through patient caregiver instruction, on the one hand, and computerisation of medical data accessible to all healthcare providers, on the other hand, might reduce drug use on a regular basis and, consequently, the costly and adverse effects of polypharmacy.
高龄、共病、功能依赖和虚弱与多重用药及总体高医疗支出相关。多重用药通常定义为同时服用四种或更多药物,尤其是在社区居住的患者中,但机构化和住院患者服用的药物数量可能高达十种。本研究的目的是比较老年医疗中心新入院的长期护理(LTC)患者(AP)与该中心机构化患者(IP)的用药情况。
2001年1月至2002年12月,对324名功能依赖且认知受损的老年患者(≥65岁)进行了一项横断面研究,其中包括167名在中心居住≥3个月的IP(127名女性,40名男性)和157名连续新入院接受LTC的患者(117名女性,40名男性)。所有患者均接受了全面的老年评估,包括结构化病史、用药史、体格检查以及功能和认知检查。比较了两组患者的总体用药情况、药物类别及用药依据(常规和/或按需)。用药模式定义为在全面老年评估前3周内的任何时间按“常规”或“按需”使用药物。
IP年龄更小,依赖性更强,认知受损更严重,共病更多,总体用药量略高于AP。AP主要按“常规”用药。所有IP和大多数(97%)AP都按常规方案用药。然而,IP中的高龄与总体用药量较低相关,主要是“常规”服用的药物,而“按需”服用的药物使用量较高,而在AP中,高龄与两种类型药物的使用量较高相关。
IP“按需”使用的药物更多,可能是因为对这些患者的医疗监督比社区患者更密切。一方面,通过患者护理指导更好地了解患者的病情和治疗情况,并在社区进行更好的监测,另一方面,使所有医疗服务提供者都能获取医疗数据的计算机化,可能会减少常规用药,从而减少多重用药的成本和不良反应。